What question did this study set out to answer?

Investigate the clinical effectiveness, safety, and metabolic processing of oral L-dopa therapy in patients with Parkinson's disease.

February 14, 1970BMJOpen Access

Metabolic Studies and Clinical Observations During L-Dopa Treatment of Parkinson's Disease

View Full Paper

Ask AI

Bookmark

Authors

MPM. J. T. PeastonUniversity of Liverpool JBJ. R. BianchineChinese University of Hong Kong

Discussion

Member takes

Implication

Clinical study demonstrates significant disability reduction and rapid drug clearance with L-dopa in Parkinson's disease, highlighting feasibility for supervised outpatient treatment.

Key Points

Investigate the clinical effectiveness, safety, and metabolic processing of oral L-dopa therapy in patients with Parkinson's disease.
Treated 22 patients with Parkinson's disease with oral L-dopa for durations of up to six months.
Assessed metabolic disposition in nine male patients following oral administration of radiolabeled carbon-14 L-dopa by measuring serum, urine, stool, and expired air excretion.
Serum radioactivity peaked at 1 to 2 hours post-ingestion, with two-thirds of the dose excreted as metabolites in urine within 8 hours.
Disability improved by an average of 47% at 30 days, 55% at 50 days, and 60% at 3 months, with greater benefit inversely associated with patient age, disease duration, and baseline severity.
Dose-limiting side effects included early nausea and late choreoathetosis, both fully reversible with dose reduction, reaching an average tolerated dose of 3 g per day.

Cite This Study

Peaston et al. (1970) studied this question.

synapsesocial.com/papers/6a7464143e32726c44092ec6 https://doi.org/10.1136/bmj.1.5693.400

View Full Paper

Ask AI

Bookmark

Implication

Clinical study demonstrates significant disability reduction and rapid drug clearance with L-dopa in Parkinson's disease, highlighting feasibility for supervised outpatient treatment.

Metabolic Studies and Clinical Observations During L-Dopa Treatment of Parkinson's Disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Metabolic Studies and Clinical Observations During L-Dopa Treatment of Parkinson's Disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider